Patients treated with infliximab for inflammatory bowel disease (IBD) showed significantly reduced response to COVID-19 antibodies, compared with those treated with vedolizumab, according to data from...
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.
NEW YORK (AP) — As states lift mask rules and ease restrictions on restaurants and...
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok